Don’t Be Left Behind. Keep Up With THE HERD!
Supportive assistance guide for your AE Journey~
October 1st 2023 Edition
In this Issue~
- *Children’s Corner (for all ages): Clinical Characteristics and Short-Term Prognosis of Children With Antibody-Mediated, Halloween Code Breaker 2-pages includes key
- *ABI Rehabilitation: Spooky Mad Libs
- *Helpful Tips for the AE Warrior: AE Trivia Playing Cards
- *Most Popular Visuals: Rituxan Side Effects, The Cat in the Hat on Autoimmune Encephalitis
- *Featured AE Article: The story of the girl who overcame encephalitis twice: ‘It’s as if I lived through it in a coma’
- *Video: How to Make the Most Out of Your Doctor’s Appointment
- *Clinician’s Corner: Mycophenolate mofetil reduces the risk of relapse in anti-leucine-rich glioma–inactivated protein 1 encephalitis: a prospective observational cohort study
- *Open Access: Long-term efficacy and safety of different corticosteroid courses plus mycophenolate mofetil for autoimmune encephalitis with neuronal surface antibodies without tumor
- *Monthly Zoom Support Groups for Patients & Caregivers: Caregiver Monthly Zoom Support Group, #AETuesdayTries for patients and caregivers
- *AE Studies & Clinical Trial: What is a Clinical Trial Video, Cielo Clinical Trial to Compare Satralizumab with placebo in anti-NMDAr and LGI1 patients, The IGNITE Study, The ExTINGUISH Trial
- *AE Trivia Cards: The Single Most Important Educational/Rehabilitation Tool for AE
- *AE Warrior Store: Shop for AE Bling and Raise Awareness. Check out our new arrivals
- *Shop & Support IAES: Sign up for PayPal’s #GiveAtCheckOut
Clinical Characteristics and Short-Term Prognosis of Children With Antibody-Mediated Autoimmune Encephalitis: A Single-Center Cohort Study
Conclusions: AE is a treatable disease that can occur in children of all ages. The mortality rate is low, as most patients have a good response to immune therapy. Compared with the older children, infants and young children (≤ 3 years old) with anti-NMDAR encephalitis have a higher incidence of fever and status epilepticus, more severe condition, higher PICU admission rate, and worse prognosis. AE patients with high maximum mRS scores and PICU admissions may require second-line immunotherapy.
Halloween Code Breaker 2-pages includes key
A Witch casts a spell on these words. Use the key provided to break the code. This is a fun Halloween activity that also acts as a cognitive rehabilitation exercise to help our younger AE Warriors re-learn and re-train their brain from brain injury caused by autoimmune encephalitis. Work on your organizational skills, memory, cognitive, reasoning, decision-making, and fine motor skills.
ABI Rehabilitation From AE
Spooky Mad Libs
Helpful Tips for Patients & Families
AE Trivia Playing Cards
Most Popular Visuals
Rituxan Side Effects
The Cat in the Hat on Autoimmune Encephalitis
Featured AE Article
The story of the girl who overcame encephalitis twice: ‘It’s as if I lived through it in a coma’
A new documentary narrates the inspiring experience of Marta Huertas, aiming to bring visibility to a rare disease that affects one person in every 250,000
Marta’s body had developed a “misdirected” immune response against NMDA receptors in the brain, which are involved in functions such as learning and memory, explains Dalmau. In these cases the prognosis is even more uncertain, because the brain has already been damaged by the virus, adds Armangué.
How to Make the Most out of Your Doctor’s Appointment
IAES Editor-in-Chief, Jeri Gore, has an informative discussion with Support Services Coordinator, Mari Wagner Davis, RN, ACM covering advice on how to best prepare for a doctor’s appointment.
Mycophenolate mofetil reduces the risk of relapse in anti-leucine-rich glioma–inactivated protein 1 encephalitis: a prospective observational cohort study
A total of 83 patients with LGI1 autoimmune encephalitis were included. Conclusion:
Although the outcome of anti-LGI1 encephalitis patients is generally favorable, relapse is common, especially in those with cognitive impairment. MMF treatment is well-tolerated and can significantly reduce the risk of relapse.
Long-term efficacy and safety of different corticosteroid courses plus mycophenolate mofetil for autoimmune encephalitis with neuronal surface antibodies without tumor
Conclusions: The beneficial effects of oral corticosteroid treatment may not persist beyond 12 months and may even contribute to an increased incidence of adverse effects. In order to optimize the effectiveness and safety of treatment, we recommend a corticosteroid course of 3-12 months. Patients with reduced levels of consciousness may be more inclined to choose longer courses of corticosteroids for long-term treatment. Patients with an “overlapping syndrome” may require more intense immunotherapy to prevent relapse.
Monthly Zoom Support Groups For Patients and Caregivers
Caregiver Monthly Zoom Support Group
AE Caregivers have a variety of unique challenges that are different from the AE Warrior’s. Often they feel alone and need to be able to share their concerns with others who are on that same journey. Sometimes hearing a chorus of ‘Me Too!’ can have great healing power of its own. Additionally, some of you may qualify for services you are unaware of that could assist or solve a challenge you (or your loved one) are having. As topics are discussed, your hostess, Mari Davis, will direct you to available solutions, services and supports.
Your Hostess, IAES Support Services Coordinator Mari Wagner Davis, has 30 years of experience as an accredited Nurse Case Manager. Mari’s professional career prior to becoming ill with Autoimmune Encephalitis was to locate and arrange for the support services needed for patients when released from the hospital to rehabilitation or home.
The next monthly #AETuesdayTries Zoom meet-up will take place on October 31st, and will always be the last Tuesday of each month.
“Tuesday Tries” addresses the emotional support and rehabilitation AE patients and caregivers require in recovering from autoimmune encephalitis by building your resilience. The program utilizes science-based exercises from the work of PERMA; Seligman, 2012.
IAES wants to foster your capacity in the belief that better days are ahead! “Tuesday Tries” is about practicing a strengths-based approach by “normalizing the try;” celebrating critical milestones in the recovery and care of AE patients and caregivers in order to build a more resilient network of care.
A workbook organizer, “Growing Your Resilience” has been created to accompany the #AETuesdayTries program and is located on the ‘Apps and Tools for AE Warriors’ page in the section: ‘Building Your Resilience’ on the IAES website under the ‘For Patients’ tab. A link to download the organizer is also provided within your e-mail confirmation when you register.
Join AE patients and caregivers of all ages and stages in their AE journey. Receive insights and encouragement from others and celebrate your critical milestones in recovery and care while building a more resilient personal AE network!
Your facilitator, Tessa McKenzie, IAES’ Chief Resilience Officer, is a life coach and studies “resilience” through her private practice, Envisage Vocation Creation and work with Johns Hopkins University’s Life Design Lab. Join Tessa and other AE patients and caregivers who are ready to “Share Your Try Tuesdays”. Tessa will provide prompts for the reframe of perceived failures as well as peer-to-peer validation of “wins” and opportunities for relationship building.
AE Studies and Clinical Trials
What Is A Clinical Trial (5-Minutes)
Cielo Clinical Trial to Compare Satralizumab with placebo in anti-NMDAr and LGI1 patients
The trial aims to show Satralizumab is safe and effective for the treatment of Autoimmune Encephalitis and become FDA-approved. Your participation will improve the lives of all future patients. Help us reach the best outcomes for all. Ask your doctor about this trial.
The ExTINGUISH Trial
The IGNITE Study
Your participation will help uncover that answer and your act of advocacy will eventually enhance lives! The first step to take is to fill out and submit the screening survey below.
Seronegative/antibody-negative patients can play an active advocacy role by distributing the IGNITE study flyer to their diagnosing doctor, and asking that it be posted at the infusion center you use, as well as hospitals and clinics you visit.
Sharing the flyer on your social media platforms will assist us in getting the highest level of participation possible.
AE Trivia Playing Cards
The perfect companion for patients, caregivers & therapists
We appreciate the National Organization of Rare Diseases’ (NORD) enthusiastic support in recommending this groundbreaking product.
AE Warrior Store
Shop for AE Bling and Raise Awareness
Shop & Support IAES Through PayPal’s
Donations raised are greatly appreciated and directly support research, patients, caregivers, and families through their journey so the best outcomes can be reached. Your contribution to our mission will help save a life and improve the quality of lives for others. Be a part of the solution by supporting IAES.
Driven by the knowledge that “Education is Power”, Int’l AE Society manages an educational support group for patients diagnosed with Autoimmune Encephalitis and their loved ones on Face Book, empowering them to be strong self-advocates and advocates that will lead them to best outcomes and recovery. We are the premiere organization leading in these vital roles.